Cagatin, Gina B.
HRN: 27-97-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2025
CEFUROXIME 1.5GM (VIAL)
12/07/2025
12/08/2025
IV
1.5grams
Q8h
S/P CS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes